Immunogenicity of experimental trachoma vaccines in baboons: I. Experimental methods, and preliminary tests with vaccines prepared in chick embryos and in HeLa cells
- 1 December 1966
- journal article
- research article
- Published by Cambridge University Press (CUP) in Epidemiology and Infection
- Vol. 64 (4) , 513-528
- https://doi.org/10.1017/s0022172400040821
Abstract
Parallel titrations of a strain of trachoma (MRC–221) and one of inclusion conjunctivitis (MRC–4) in the baboon conjunctiva and in chick embryos suggest that ten to twenty 50% egg infective doses are equivalent to one 50% baboon infective dose; but that at least 1000 egg infective doses are needed to induce moderate or severe infections in all of a given number of baboons.For vaccine experiments in baboons, a system of scoring physical signs and presence of inclusion bodies was devised; the significance of differences in vaccinated and control animals in their response to conjunctival challenge was determined by analysis of variance. An aqueous suspension of live MRC–4 grown in the yolk sac was given as two subcutaneous doses and one intravenous dose at weekly intervals, and protected all of six baboons challenged with the homologous strain; three similarly spaced subcutaneous doses were less effective. The immunity induced by this vaccine waned considerably during the ensuing 15 months. Vaccine prepared from a live ‘fast-killing’ variant of MRC–4 grown in HeLa cells was less effective than MRC–4 itself in protecting baboons against infection with the parent strain.Although both yolk sac and HeLa cell vaccines induced the formation of antibody fixing complement with trachoma group antigen, the serum titres in individual animals at the time of challenge were unrelated to the degree of protection; during a 15 month observation period there were pronounced falls in the titres of antibody induced either by vaccination or by challenge with egg-grown TRIC agent.We wish to thank Dr I. Sutherland (M.R.C. Statistical Research Unit) for his helpful advice during the early stages of this work. We are also greatly indebted to Mr P. Avis (Pfizer Ltd.) for his advice and for undertaking the statistical computations; and to Miss Anne Smith and Miss Pay Storey (M.R.C. Trachoma Research Unit) for doing the complement fixation tests.This publication has 32 references indexed in Scilit:
- Growth and Neutralization of the Trachoma Agent In Mouse LungsNature, 1965
- Growth in the Chick Embryo of Strains of Trachoma and Inclusion Blennorrhoea Virus of Differing VirulenceJournal of General Microbiology, 1964
- Toxicity of the Agents of Trachoma and Inclusion ConjunctivitisJournal of General Microbiology, 1964
- Nomenclature of Isolates of Virus from Trachoma and Inclusion BlennorrhœaNature, 1963
- Some Properties of the Complement-fixing Antigens of the Agents of Trachoma and Inclusion Blennorrhoea and the Relationship of the Antigens to the Developmental CycleJournal of General Microbiology, 1962
- One-step Growth Curves for Inclusion Blennorrhoea Virus in HeLa Cell MonolayersJournal of General Microbiology, 1962
- EXPERIMENTS WITH TRACHOMA VACCINES Experimental System Using Inclusion Blennorrh$oelig;a VirusThe Lancet, 1961
- The Titration of Trachoma and Inclusion Blennorrhoea Viruses in Cell CulturesJournal of General Microbiology, 1960
- PLAQUE FORMATION AND ISOLATION OF PURE LINES WITH POLIOMYELITIS VIRUSESThe Journal of Experimental Medicine, 1954
- The Serological Comparison of Strains of Influenza VirusJournal of General Microbiology, 1949